Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 2/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21213550 | 1.00 | NPY5R (0.31) | NPY5RESR1ESR2 | |
| SCHEMBL21213438 | 0.97 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL21212948 | 0.88 | PIK3CA (0.34) | ESR1ESR2 | |
| SCHEMBL21213183 | 0.88 | PIK3CA (0.34) | ESR1ESR2 | |
| SCHEMBL21212910 | 0.88 | HPGD (0.33) | ESR1ESR2 | |
| SCHEMBL21213506 | 0.88 | ESR1 (0.37) | NPY5RESR1ESR2 | |
| SCHEMBL21213715 | 0.88 | ESR1 (0.37) | NPY5RESR1ESR2 | |
| SCHEMBL21213811 | 0.88 | ESR1 (0.37) | NPY5RESR1ESR2 | |
| SCHEMBL21213505 | 0.88 | ESR1 (0.37) | NPY5RESR1ESR2 | |
| SCHEMBL21213202 | 0.87 | ESR1 (0.38) | NPY5RESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CYP1B1, CYP2C9, CYP3A4 | NPY5R 3563/4885ESR1 424/4885ESR2 1690/4885 |
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | CYP1B1, CYP2C9, CYP3A4 | NPY5R 3563/4885ESR1 424/4885ESR2 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.